Literature DB >> 22301250

Infection following total knee arthroplasty: prevention and management.

Kevin L Garvin1, Beau S Konigsberg.   

Abstract

Despite diligent efforts to prevent infection, prosthetic knee infection occurs in up to 2% of patients treated with total knee arthroplasty. Although the risk of infection is relatively low, the effects are considerable. The number of total knee arthroplasties is projected to increase by more than 600% by 2030, resulting in 3.48 million knee replacements, with a possible 70,000 prosthetic knee infections. Infection will be the most common indication for revision total knee arthroplasty. Prophylactic antibiotics and minimizing patient risk factors are critical in preventing infections. Staphylococcus is the most common organism in infected total knee arthroplasties. Prompt diagnosis and treatment are crucial to the long-term outcomes of patients with prosthetic joint infections. The erythrocyte sedimentation rate, C-reactive protein level, and interleukin-6 serum level should be checked in all patients with clinical signs of infection or unexplained pain or stiffness. The surgical management of a prosthetic knee infection depends on several factors, but none is more important than the timing of infection in relationship to the index surgery. With a success rate of 80% to 90%, two-stage component exchange remains the treatment of choice for chronically infected total knee arthroplasties.

Entities:  

Mesh:

Year:  2012        PMID: 22301250

Source DB:  PubMed          Journal:  Instr Course Lect        ISSN: 0065-6895


  15 in total

1.  Surgical approaches in total knee arthroplasty.

Authors:  Marco Sanna; Cristina Sanna; Francesco Caputo; Giuseppe Piu; Massimiliano Salvi
Journal:  Joints       Date:  2013-10-24

Review 2.  Amputation as a Complication after Total Knee Replacement, is it a Real Concern to be Discussed?: A Systematic Review.

Authors:  Alireza Mousavian; Soheil Sabzevari; Shirin Ghiasi; Omid Shahpari; Amin Razi; Adel Ebrahimpour; Mohammad H Ebrahimzadeh
Journal:  Arch Bone Jt Surg       Date:  2021-01

3.  Metal artefact reduction in MRI at both 1.5 and 3.0 T using slice encoding for metal artefact correction and view angle tilting.

Authors:  M Reichert; T Ai; J N Morelli; M Nittka; U Attenberger; V M Runge
Journal:  Br J Radiol       Date:  2015-01-23       Impact factor: 3.039

4.  Normal CRP and WBC values in total hip arthroplasty (THA) with signs of loosening. Do we need a joint aspiration?

Authors:  Erik Schiffner; David Latz; Simon Thelen; Jan P Grassmann; Alfred Karbowski; Joachim Windolf; Johannes Schneppendahl; Pascal Jungbluth
Journal:  J Clin Orthop Trauma       Date:  2018-09-26

5.  Two-stage revision total knee arthroplasty in cases of periprosthetic joint infection: an analysis of 50 cases.

Authors:  Leif Claassen; Christian Plaass; Kiriakos Daniilidis; Tilman Calliess; Gabriela von Lewinski
Journal:  Open Orthop J       Date:  2015-02-27

Review 6.  Prevention of Periprosthetic Joint Infection.

Authors:  Alisina Shahi; Javad Parvizi
Journal:  Arch Bone Jt Surg       Date:  2015-04

7.  Improving environmental quality in an operating room: clinical outcomes and economic implications.

Authors:  M Sartini; A M Spagnolo; D Panatto; F Perdelli; M L Cristina
Journal:  J Prev Med Hyg       Date:  2013-06

8.  Periprosthetic Fungal Infections in Severe Endoprosthetic Infections of the Hip and Knee Joint-A Retrospective Analysis of a Certified Arthroplasty Centre of Excellence.

Authors:  Andreas Enz; Silke C Mueller; Philipp Warnke; Martin Ellenrieder; Wolfram Mittelmeier; Annett Klinder
Journal:  J Fungi (Basel)       Date:  2021-05-21

Review 9.  Low-grade periprosthetic knee infection: diagnosis and management.

Authors:  Michele Vasso; Alfredo Schiavone Panni
Journal:  J Orthop Traumatol       Date:  2014-05-14

10.  Diagnosing periprosthetic joint infection: has the era of the biomarker arrived?

Authors:  Carl Deirmengian; Keith Kardos; Patrick Kilmartin; Alexander Cameron; Kevin Schiller; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2014-11       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.